Chen, R. 2025. Semaglutide as a Novel Therapeutic Agent for Obesity and Type 2 Diabetes. Transactions on Materials, Biotechnology and Life Sciences. 8, (Oct. 2025), 454–459. DOI:https://doi.org/10.62051/5008za94.